Identification of biomarkers of immune checkpoint blockade efficacy in recurrent or refractory solid tumor malignancies

Patients with advanced solid malignancies recurrent or resistant to standard therapy have limited treatment options. The role of molecular biomarkers for predicting immune checkpoint blockade (ICB) efficacy are not well characterized in these patients. Tumor mutational profiles of 490 patients with...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Yang, Richard K., Qing, Yun, Jelloul, Fatima Zahra, Routbort, Mark J., Wang, Peng, Shaw, Kenna, Zhang, Jiexin, Lee, Jack, Medeiros, L. Jeffrey, Kopetz, Scott, Tetzlaff, Michael T., Broaddus, Russell R.
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2020
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7021232/
https://ncbi.nlm.nih.gov/pubmed/32110280
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27466
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados